STOCK TITAN

CYPHERPUNK (CYPH) director sells 60K shares to cover RSU taxes

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

CYPHERPUNK TECHNOLOGIES INC. director Christopher Mirabelli reported an open-market sale of 60,000 shares of Common Stock at an average price of $0.7105 per share on March 26, 2026. According to the footnote, the sale was made to cover estimated taxes related to a previously reported settlement of RSUs on March 13, 2026. After this transaction, Mirabelli directly owns 130,376 shares of the company’s common stock.

Positive

  • None.

Negative

  • None.
Insider Mirabelli Christopher
Role Director
Sold 60,000 shs ($43K)
Type Security Shares Price Value
Sale Common Stock 60,000 $0.7105 $43K
Holdings After Transaction: Common Stock — 130,376 shares (Direct)
Footnotes (1)
  1. [object Object]
Shares sold 60,000 shares Common Stock sold on March 26, 2026
Sale price per share $0.7105 per share Average price for 60,000 shares sold
Shares owned after sale 130,376 shares Direct ownership after March 26, 2026 transaction
Net shares sold 60,000 shares Net-sell direction in transaction summary
RSU settlement date March 13, 2026 RSU settlement triggering estimated tax obligation
open-market sale financial
"reported an open-market sale of 60,000 shares of Common Stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Restricted Stock Units financial
"in connection with the previously reported settlement of RSUs"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"settlement of RSUs on March 13, 2026"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
estimated taxes financial
"shares sold by the Reporting Person to cover estimated taxes"
Form 4 regulatory
"The sale reported on this Form 4 represents shares sold"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mirabelli Christopher

(Last)(First)(Middle)
C/O CYPHERPUNK TECHNOLOGIES INC.
47 THORNDIKE STREET SUITE B1-1

(Street)
CAMBRIDGE MASSACHUSETTS 02141

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CYPHERPUNK TECHNOLOGIES INC. [ CYPH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/26/2026S(1)60,000D$0.7105130,376D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the previously reported settlement of RSUs on March 13, 2026.
/s/ Douglas E. Onsi as attorney-in-fact for the reporting person03/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CYPH director Christopher Mirabelli report?

Christopher Mirabelli reported selling 60,000 shares of CYPHERPUNK TECHNOLOGIES INC. common stock at $0.7105 per share. The Form 4 states this open-market transaction was made to cover estimated taxes arising from a previously reported RSU settlement on March 13, 2026.

Why did Christopher Mirabelli sell CYPH shares according to the Form 4?

The filing explains that Mirabelli sold 60,000 CYPH shares to cover estimated taxes owed in connection with a previously reported settlement of restricted stock units (RSUs) on March 13, 2026. This characterizes the sale as tax-related rather than a discretionary liquidation.

How many CYPH shares does Christopher Mirabelli hold after the reported sale?

After selling 60,000 shares, Mirabelli directly owns 130,376 shares of CYPHERPUNK TECHNOLOGIES INC. common stock. This post-transaction figure, disclosed in the Form 4, helps show that he retains a significant continuing equity stake in the company following the tax-related sale.

What was the sale price for the CYPH shares in Mirabelli’s Form 4?

The Form 4 reports that the 60,000 CYPH common shares were sold at an average price of $0.7105 per share. This price reflects the consideration received in the open-market sale used to cover estimated tax obligations linked to an earlier RSU settlement.

Does the CYPH Form 4 mention derivative or option positions for Mirabelli?

The provided Form 4 data shows no derivative transactions and an empty derivative position summary for Mirabelli. The filing focuses solely on the 60,000-share common stock sale tied to estimated tax payments from the settlement of restricted stock units on March 13, 2026.
Leap Therapeutic

NASDAQ:LPTX

View LPTX Stock Overview

LPTX Rankings

LPTX Latest News

LPTX Latest SEC Filings

LPTX Stock Data

116.14M
49.89M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE